Coya Therapeutics News

Coya Therapeutics | DEFA14A: Others

Mar 29 13:53 ET

Coya Therapeutics | ARS: Annual Report to Security Holders

Mar 28 22:41 ET

Coya Therapeutics | DEFA14A: Others

Mar 28 16:41 ET

Coya Therapeutics | DEF 14A: Definitive information statements

Mar 28 16:37 ET

Coya Therapeutics | 10-K: Annual report

Mar 19 08:31 ET

Coya Therapeutics | 8-K: Current report

Mar 19 08:26 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Ann

Mar 5 20:04 ET

Coya Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Einhorn(8.8%),DME Advisors GP, LLC(5.8%), etc.

Feb 14 16:51 ET

Coya Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Investment Partners, L.L.C.(.9%),Orin H(8.1%), etc.

Feb 7 18:57 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grossman Fred

Feb 2 20:02 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SNYDER DAVID S

Feb 2 20:02 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Berman Howard

Feb 2 20:01 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Weinand Dieter

Jan 19 00:00 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Garren Hideki

Jan 19 00:00 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDSTEIN DOV A MD

Jan 19 00:00 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Ann

Jan 19 00:00 ET

Coya Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Villalobos Anabella

Jan 19 00:00 ET

Coya Therapeutics | 8-K: Current report

Jan 19 00:00 ET

Coya Therapeutics | 424B3: Prospectus

Jan 16 00:00 ET

Coya Therapeutics | EFFECT: Others

Jan 16 00:00 ET